Paul G Thomas

Dr. Paul G Thomas

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2017 in Nature
Verified
Journal Article
Closed access
PDF file
PDPradyot Dash
Pradyot Dash
AFAndrew J. Fiore-Gartland
Andrew J. Fiore-Gartland
THTomer Hertz
Tomer Hertz
GWGeorge C. Wang
George C. Wang
SSShalini Sharma
Shalini Sharma
PTPaul G Thomas
Paul G Thomas

1 June 2017 in Cell
Verified
Journal Article
Closed access
HGHazem E. Ghoneim
Hazem E. Ghoneim
YFYiping Fan
Yiping Fan
AMArdiana Moustaki
Ardiana Moustaki
HAHossam A. Abdelsamed
Hossam A. Abdelsamed
PDPradyot Dash
Pradyot Dash
BYBen Youngblood
Ben Youngblood

1 September 2017 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MSMikhail Shugay
Mikhail Shugay
DBDmitriy V Bagaev
Dmitriy V Bagaev
IZIvan V Zvyagin
Ivan V Zvyagin
RVRenske M Vroomans
Renske M Vroomans
JCJeremy Chase Crawford
Jeremy Chase Crawford
DCDmitriy M Chudakov
Dmitriy M Chudakov
The ability to decode antigen specificities encapsulated in the sequences of rearranged T-cell receptor (TCR) genes is critical for our understanding of the adaptive immune system and promises significant advances in the field of translational medicine. Recent developments in high-throughput sequencing methods (immune repertoire sequencing technology, or RepSeq) and single-cell RNA sequencing technology have allowed us to obtain huge numbers of TCR sequences from donor samples and link them to T-cell phenotypes. However, our ability to annotate these TCR sequences still lags behind, owing to the enormous diversity of the TCR repertoire and the scarcity of available data on T-cell specificities. In this paper, we present VDJdb, a database that stores and aggregates the results of published T-cell specificity assays and provides a universal platform that couples antigen specificities with TCR sequences. We demonstrate that VDJdb is a versatile instrument for the annotation of TCR repertoire data, enabling a concatenated view of antigen-specific TCR sequence motifs. VDJdb can be accessed at https://vdjdb.cdr3.net and https://github.com/antigenomics/vdjdb-db.

1 April 2009 in Immunity
Verified
Journal Article
Closed access
PTPaul G Thomas
Paul G Thomas
PDPradyot Dash
Pradyot Dash
JAJerry R. Aldridge
Jerry R. Aldridge
AEAli H. Ellebedy
Ali H. Ellebedy
CRCory Reynolds
Cory Reynolds
Thirumala-Devi KannegantiThirumala-Devi Kanneganti
Thirumala-Devi Kanneganti

1 March 2020 in Cell
Verified
Journal Article
Closed access
TZTing Zhang
Ting Zhang
CYChaoran Yin
Chaoran Yin
DBDavid F. Boyd
David F. Boyd
GQGiovanni Quarato
Giovanni Quarato
JIJustin P. Ingram
Justin P. Ingram
SBSiddharth Balachandran
Siddharth Balachandran

19 July 2019 in Critical Care
Verified
Journal Article
Open access
PDF file
AKAndre C. Kalil
Andre C. Kalil
PTPaul G Thomas
Paul G Thomas
Influenza virus affects the respiratory tract by direct viral infection or by damage from the immune system response. In humans, the respiratory epithelium is the only site where the hemagglutinin (HA) molecule is effectively cleaved, generating infectious virus particles. Virus transmission occurs through a susceptible individual’s contact with aerosols or respiratory fomites from an infected individual. The inability of the lung to perform its primary function of gas exchange can result from multiple mechanisms, including obstruction of the airways, loss of alveolar structure, loss of lung epithelial integrity from direct epithelial cell killing, and degradation of the critical extracellular matrix. Approximately 30–40% of hospitalized patients with laboratory-confirmed influenza are diagnosed with acute pneumonia. These patients who develop pneumonia are more likely to be < 5 years old, > 65 years old, Caucasian, and nursing home residents; have chronic lung or heart disease and history of smoking, and are immunocompromised. Influenza can primarily cause severe pneumonia, but it can also present in conjunction with or be followed by a secondary bacterial infection, most commonly by Staphylococcus aureus and Streptococcus pneumoniae. Influenza is associated with a high predisposition to bacterial sepsis and ARDS. Viral infections presenting concurrently with bacterial pneumonia are now known to occur with a frequency of 30–50% in both adult and pediatric populations. The H3N2 subtype has been associated with unprecedented high levels of intensive care unit (ICU) admission. Influenza A is the predominant viral etiology of acute respiratory distress syndrome (ARDS) in adults. Risk factors independently associated with ARDS are age between 36 and 55 years old, pregnancy, and obesity, while protective factors are female sex, influenza vaccination, and infections with Influenza A (H3N2) or Influenza B viruses. In the ICU, particularly during the winter season, influenza should be suspected not only in patients with typical symptoms and epidemiology, but also in patients with severe pneumonia, ARDS, sepsis with or without bacterial co-infection, as well as in patients with encephalitis, myocarditis, and rhabdomyolysis.